Pricing Log in Create free account
Saturday 17 October 2026 Export CLPT’s income statement to Excel — free account

ClearPoint Neuro, Inc.

CLPT Healthcare Medical Devices

ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS fell 81.0%, free cash flow fell 173.5% and total debt rose 74.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

9.07 0.57 −5.91%
Market cap
$294.1M
P/E
0.0×
Fwd P/E
−11.6×
Dividend yield
—
F-score
4/9
Altman Z
0.44
Beneish M
−1.74
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

ClearPoint Neuro, Inc. (CLPT) Business Profile

Updated before January 2025

Company Overview

ClearPoint Neuro, Inc. (CLPT), headquartered in Solana Beach, California, is a medical device company specializing in innovative solutions for minimally invasive neurosurgery. Founded in 1998, the company was initially known as MRI Interventions, Inc., before rebranding to ClearPoint Neuro in 2020 to better reflect its mission and focus. The company’s leadership team includes Joseph Burnett, who serves as the President and Chief Executive Officer, and other seasoned executives with extensive experience in the medical device and healthcare industries. ClearPoint Neuro is dedicated to advancing patient care through its cutting-edge technologies and services, which are designed to improve the precision and safety of neurosurgical procedures.

Core Business Segments

ClearPoint Neuro operates in the following core business segments:

1. ClearPoint Neuro Navigation System

The ClearPoint Neuro Navigation System is the company’s flagship product. It is a state-of-the-art platform that enables real-time, MRI-guided navigation for minimally invasive neurosurgical procedures. This system is widely used for procedures such as deep brain stimulation (DBS), laser ablation, and drug delivery to the brain. Key components of the system include:

  • ClearPoint SmartFrame: A stereotactic frame that provides precise targeting and trajectory guidance.
  • ClearPoint Software: Proprietary software that integrates with MRI imaging to offer real-time visualization and navigation.
  • ClearPoint Disposable Products: A range of single-use devices designed to enhance the safety and efficiency of neurosurgical procedures.

2. Biologics and Drug Delivery

ClearPoint Neuro collaborates with pharmaceutical and biotech companies to develop and deliver therapies directly to the brain. The company’s platform is used in clinical trials and research for conditions such as Parkinson’s disease, epilepsy, and brain tumors. This segment includes:

  • Drug Delivery Systems: Tools and technologies for precise delivery of therapeutic agents.
  • Partnerships with Biotech Firms: Collaborations to advance gene therapy and other innovative treatments.

3. Service and Support

ClearPoint Neuro provides comprehensive support services to its customers, including:

  • Clinical Support: On-site assistance during procedures to ensure optimal use of the ClearPoint system.
  • Training and Education: Programs for surgeons and medical staff to enhance their proficiency with the company’s technologies.
  • Maintenance and Upgrades: Ongoing support to keep systems operational and up-to-date.

Business Model

ClearPoint Neuro’s business model is centered around the integration of its products and services to create a seamless experience for its customers. The company generates revenue through:

  • Product Sales: Revenue from the sale of ClearPoint systems, disposable products, and accessories.
  • Service Contracts: Income from maintenance, training, and clinical support services.
  • Collaborations and Licensing: Revenue from partnerships with biotech and pharmaceutical companies for drug delivery and therapy development.

This integrated approach allows ClearPoint Neuro to build long-term relationships with its customers and partners while driving recurring revenue streams.

Strategic Direction

ClearPoint Neuro is focused on expanding its market presence and advancing its technologies to address unmet medical needs. Key strategic initiatives include:

  • Geographic Expansion: Increasing its footprint in international markets, particularly in Europe and Asia.
  • Product Innovation: Developing new tools and technologies to enhance the capabilities of the ClearPoint system.
  • Sustainability Goals: Implementing environmentally friendly practices in product design and manufacturing.
  • Clinical Trials and Research: Partnering with leading institutions to explore new applications for its platform, such as gene therapy and neurodegenerative disease treatment.

Competitive Landscape

ClearPoint Neuro operates in a competitive market that includes both established medical device companies and emerging startups. Key competitors include:

  • Medtronic: A global leader in medical technology, offering solutions for neurosurgery and deep brain stimulation.
  • Boston Scientific: Known for its neuromodulation devices and other medical technologies.
  • Brainlab: Specializes in image-guided surgery and radiotherapy solutions.
  • Monteris Medical: Focused on laser ablation systems for neurosurgery.

Despite the competition, ClearPoint Neuro differentiates itself through its focus on MRI-guided navigation and its strong partnerships with biotech firms.

Risk Factors

ClearPoint Neuro faces several risks that could impact its business, including:

  • Market Dependence: Reliance on the adoption of its technologies by hospitals and surgical centers.
  • Regulatory Challenges: Compliance with stringent medical device regulations in different countries.
  • Supply Chain Disruptions: Potential delays in the production and delivery of its products.
  • Competition: Pressure from larger companies with more extensive resources.

Recent Developments

ClearPoint Neuro has made significant strides in recent years, including:

  • New Product Launches: Introduction of advanced tools and software updates for the ClearPoint system.
  • Partnerships: Collaborations with leading biotech companies to advance gene therapy research.
  • Global Expansion: Establishing a presence in new markets to drive growth.
  • COVID-19 Impact: Adjusting operations to address challenges posed by the pandemic, such as supply chain disruptions and changes in surgical volumes.

Investment Considerations

Investors considering ClearPoint Neuro should weigh the following factors:

Strengths:

  • Innovative technology with a strong focus on MRI-guided neurosurgery.
  • Growing market for minimally invasive procedures and drug delivery.
  • Strong partnerships with biotech and pharmaceutical companies.

Risks:

  • Dependence on a niche market with limited customer base.
  • Competition from larger, well-established medical device companies.
  • Potential regulatory and reimbursement challenges.

Conclusion

ClearPoint Neuro, Inc. is a pioneering company in the field of MRI-guided neurosurgery, offering innovative solutions that improve patient outcomes and advance medical research. With a strong focus on product innovation, strategic partnerships, and market expansion, the company is well-positioned for future growth. However, investors should carefully consider the risks associated with its niche market and competitive landscape. Overall, ClearPoint Neuro represents a compelling opportunity for those seeking exposure to the rapidly evolving field of neurosurgical technologies.